APA (7th ed.) Citation

Kobayakawa, M., Shiga, T., Takahashi, K., Sugawara, S., Nomura, K., Hanada, K., . . . Ito, H. (2024). Evaluation of pharmacokinetics, safety, and efficacy of [211At] meta-astatobenzylguanidine ([211At] MABG) in patients with pheochromocytoma or paraganglioma (PPGL): A study protocol. PLoS ONE, 19(5), 1. https://doi.org/10.1371/journal.pone.0303623

Chicago Style (17th ed.) Citation

Kobayakawa, Masao, Tohru Shiga, Kazuhiro Takahashi, Shigeyasu Sugawara, Kaori Nomura, Kazuhiko Hanada, Naoki Ishizuka, and Hiroshi Ito. "Evaluation of Pharmacokinetics, Safety, and Efficacy of [211At] Meta-astatobenzylguanidine ([211At] MABG) in Patients with Pheochromocytoma or Paraganglioma (PPGL): A Study Protocol." PLoS ONE 19, no. 5 (2024): 1. https://doi.org/10.1371/journal.pone.0303623.

MLA (9th ed.) Citation

Kobayakawa, Masao, et al. "Evaluation of Pharmacokinetics, Safety, and Efficacy of [211At] Meta-astatobenzylguanidine ([211At] MABG) in Patients with Pheochromocytoma or Paraganglioma (PPGL): A Study Protocol." PLoS ONE, vol. 19, no. 5, 2024, p. 1, https://doi.org/10.1371/journal.pone.0303623.